Skip Navigation



European Heart Journal Advance Access published online on September 28, 2007
European Heart Journal, doi:10.1093/eurheartj/ehm434
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/21/2563    most recent
ehm434v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sniderman, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sniderman, A. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

The apoB/apoA-I ratio and insulin resistance: sorting out the metabolic syndrome

Allan D. Sniderman

Mike Rosenbloom Laboratory for Cardiovascular Research, Royal Victoria Hospital, McGill University Health Centre, 687 Pine Avenue West Montreal, Quebec H3A 1A1, Canada

Corresponding author. Tel: +1 514-934-1934 ext. 34637; fax: +1 514-843-2843. E- mail address: allansniderman@hotmail.com

This editorial refers to ‘ApoB/ApoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects’ by J. Sierra-Johnson et al., doi:10.1093/eurheartj/ehm360

The first 10% of the full text of this article appears below.

Sierra-Johnson et al.1 demonstrate that the apoB/apoA-I ratio is an independent predictor of insulin resistance in non-diabetic Americans. This was the case in men and women and was independent of the traditional risk factors, components of the metabolic syndrome, and inflammatory risk markers such as C-reactive protein (CRP). The strengths of this study are the meticulous construction of the NHANES database on which it is based and the meticulous analysis of it that was undertaken. Previously, these authors and others have shown that the apoB/apoA-I ratio becomes progressively more abnormal as the number of components of the metabolic syndrome increases2 and that apoB is more closely tied to dysglycaemia and inflammation than low-density lipoprotein (LDL) cholesterol or non-high-density . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects
Justo Sierra-Johnson, Abel Romero-Corral, Virend K. Somers, Francisco Lopez-Jimenez, Göran Walldius, Anders Hamsten, Mai-Lis Hellénius, and Rachel M. Fisher
EHJ 2007 28: 2637-2643. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 Eur Heart JHome page
J. Sierra-Johnson, R. M. Fisher, A. Romero-Corral, V. K. Somers, F. Lopez-Jimenez, J. Ohrvik, G. Walldius, M.-L. Hellenius, and A. Hamsten
Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population
Eur. Heart J., March 2, 2009; 30(6): 710 - 717.
[Abstract] [Full Text] [PDF]